Skip to main content

Fox Chase Cancer Center Joins Dharmacon s Global RNAi Alliance

NEW YORK, April 4 (GenomeWeb News) - Dharmacon, a unit of Fisher Biosciences, said today that Philadelphia's Fox Chase Cancer Center has joined Dharmacon's Genome-Wide RNAi Global Initiative.

 

Fox Chase becomes the 11th member of the alliance, and the first new member since the initiative was formed in October.

 

The alliance aims to use Dharmacon's complete siRNA library to conduct functional genomics screens of genes throughout the human genome.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.